Cardiovascular

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide. At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heart beats (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure (hypertension) or heart attack (myocardial infarction).


Deep Vein Thrombosis (DVT) is a serious but usually treatable medical condition. DVT occurs when a blood clot forms within a deep vein in a leg, thigh or even the arm. If part of the clot breaks off and travels to the lung, it can cause a potentially life-threatening condition known as pulmonary embolism (PE) which is the most serious complication of DVT. It is essential that patients with DVT or PE are quickly diagnosed then treated to prevent clot growth and future clot formation. 

General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers